SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.84+3.8%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (19017)4/14/1998 9:15:00 AM
From: Mudcat  Read Replies (2) of 32384
 
Henry: I'm not moaning and groaning but I think a major problem with these news articles is that Ligand is never mentioned in them. (Maybe I should not say never mentioned because I'm sure you will find 1 or 2 out of the thousands you post where Lgnd is mentioned.) With all the areas Lgnd is conducting research in, most articles can relate to Ligand in some way. I'm just saying it would be nice if the articles mentioned Ligand at least some of the time. For example the Times article said they are looking at other drugs to react with Tamoxifen. Why didn't the reporter say Targretin or Panretin are two of the other drugs being looked at to work with Tamoxifen. Is this just poor or lazy research by the reporter or are there many other drugs that are being considered beside Ligands?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext